Moderna Inc (MRNA)

198.00
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    198.00 - 198.00

MRNA Overview

Prev. Close
190
Day's Range
198-198
Revenue
14.18B
Open
198
52 wk Range
120.35-210
EPS
29.52
Volume
0
Market Cap
66.96B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
59
P/E Ratio
5.90
Beta
1.73
1-Year Change
13.79%
Shares Outstanding
384,180,469
Next Earnings Date
Feb 22, 2023
What is your sentiment on Moderna?
or
Market is currently closed. Voting is open during market hours.

Moderna Inc News

Moderna Inc Analysis

Moderna Inc Company Profile

Moderna Inc Company Profile

  • Type:Equity
  • Market:Peru
  • ISIN:US60770K1079
  • S/N:MRNA

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.

Read More

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesBuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyBuyNeutral
SummaryStrong BuyStrong BuyBuy